Advertisement
Review Article| Volume 50, ISSUE 1, P81-89, February 2023

The Association Between the Urinary Microbiome and Bladder Cancer

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Urologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer statistics, 2022.
        CA Cancer J Clin. 2022; 72: 7-33
        • Saginala K.
        • Barsouk A.
        • Aluru J.S.
        • et al.
        Epidemiology of bladder cancer.
        Med Sci (Basel). 2020; 8
        • Costello E.K.
        • Stagaman K.
        • Dethlefsen L.
        • et al.
        The application of ecological theory toward an understanding of the human microbiome.
        Science. 2012; 336: 1255-1262
        • Dzutsev A.
        • Goldszmid R.S.
        • Viaud S.
        • et al.
        The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
        Eur J Immunol. 2015; 45: 17-31
        • Whiteside S.A.
        • Razvi H.
        • Dave S.
        • et al.
        The microbiome of the urinary tract--a role beyond infection.
        Nat Rev Urol. 2015; 12: 81-90
        • Fouts D.E.
        • Pieper R.
        • Szpakowski S.
        • et al.
        Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury.
        J Transl Med. 2012; 10: 174
        • Goodrich J.K.
        • Di Rienzi S.C.
        • Poole A.C.
        • et al.
        Conducting a microbiome study.
        Cell. 2014; 158: 250-262
        • Durban A.
        • Abellan J.J.
        • Jimenez-Hernandez N.
        • et al.
        Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome.
        Environ Microbiol Rep. 2012; 4: 242-247
        • Ahn J.
        • Sinha R.
        • Pei Z.
        • et al.
        Human gut microbiome and risk for colorectal cancer.
        J Natl Cancer Inst. 2013; 105: 1907-1911
        • Petrov V.A.
        • Saltykova I.V.
        • Zhukova I.A.
        • et al.
        Analysis of gut microbiota in patients with parkinson's disease.
        Bull Exp Biol Med. 2017; 162: 734-737
        • Thomas-White K.J.
        • Hilt E.E.
        • Fok C.
        • et al.
        Incontinence medication response relates to the female urinary microbiota.
        Int Urogynecol J. 2016; 27: 723-733
        • Wu P.
        • Chen Y.
        • Zhao J.
        • et al.
        Urinary Microbiome and Psychological Factors in Women with Overactive Bladder.
        Front Cell Infect Microbiol. 2017; 7: 488
        • Pearce M.M.
        • Hilt E.E.
        • Rosenfeld A.B.
        • et al.
        The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.
        mBio. 2014; 5: e01283-14
        • Siddiqui H.
        • Lagesen K.
        • Nederbragt A.J.
        • et al.
        Alterations of microbiota in urine from women with interstitial cystitis.
        BMC Microbiol. 2012; 12: 205
        • Forman D.
        • de Martel C.
        • Lacey C.J.
        • et al.
        Global burden of human papillomavirus and related diseases.
        Vaccine. 2012; 30: F12-F23
        • Walboomers J.M.
        • Jacobs M.V.
        • Manos M.M.
        • et al.
        Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
        J Pathol. 1999; 189: 12-19
        • El-Omar E.M.
        • Oien K.
        • El-Nujumi A.
        • et al.
        Helicobacter pylori infection and chronic gastric acid hyposecretion.
        Gastroenterology. 1997; 113: 15-24
        • Buc E.
        • Dubois D.
        • Sauvanet P.
        • et al.
        High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.
        PLoS One. 2013; 8: e56964
        • Cambier S.
        • Sylvester R.J.
        • Collette L.
        • et al.
        EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus calmette-guerin.
        Eur Urol. 2016; 69: 60-69
        • Babjuk M.
        • Bohle A.
        • Burger M.
        • et al.
        EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016.
        Eur Urol. 2017; 71: 447-461
        • Yatsunenko T.
        • Rey F.E.
        • Manary M.J.
        • et al.
        Human gut microbiome viewed across age and geography.
        Nature. 2012; 486: 222-227
        • Zhu L.
        • Liu W.
        • Alkhouri R.
        • et al.
        Structural changes in the gut microbiome of constipated patients.
        Physiol Genomics. 2014; 46: 679-686
        • Bucevic Popovic V.
        • Situm M.
        • Chow C.T.
        • et al.
        The urinary microbiome associated with bladder cancer.
        Sci Rep. 2018; 8: 12157
        • Xu W.
        • Yang L.
        • Lee P.
        • et al.
        Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.
        Am J Clin Exp Urol. 2014; 2: 57-61
        • Hussein A.A.
        • Elsayed A.S.
        • Durrani M.
        • et al.
        Investigating the association between the urinary microbiome and bladder cancer: An exploratory study.
        Urol Oncol. 2021; 39: 370 e9-370 e19
        • Wu P.
        • Zhang G.
        • Zhao J.
        • et al.
        Profiling the urinary microbiota in male patients with bladder cancer in china.
        Front Cell Infect Microbiol. 2018; 8: 167
        • Zeng J.
        • Zhang G.
        • Chen C.
        • et al.
        Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: a single-institution study.
        Front Cell Infect Microbiol. 2020; 10: 555508
        • Bi H.
        • Tian Y.
        • Song C.
        • et al.
        Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer.
        J Med Microbiol. 2019; 68: 1471-1478
        • Chipollini J.
        • Wright J.R.
        • Nwanosike H.
        • et al.
        Characterization of urinary microbiome in patients with bladder cancer: results from a single-institution, feasibility study.
        Urol Oncol. 2020; 38: 615-621
        • Oresta B.
        • Braga D.
        • Lazzeri M.
        • et al.
        The microbiome of catheter collected urine in males with bladder cancer according to disease stage.
        J Urol. 2021; 205: 86-93
        • Liu F.
        • Liu A.
        • Lu X.
        • et al.
        Dysbiosis signatures of the microbial profile in tissue from bladder cancer.
        Cancer Medicine. 2019; 8: 6904-6914
        • Lewis D.A.
        • Brown R.
        • Williams J.
        • et al.
        The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults.
        Front Cell Infect Microbiol. 2013; 3: 41
        • Pederzoli F.
        • Ferrarese R.
        • Amato V.
        • et al.
        Sex-specific alterations in the urinary and tissue microbiome in therapy-naive urothelial bladder cancer patients.
        Eur Urol Oncol. 2020; 3: 784-788
        • Matsumoto S.
        • Hara T.
        • Nagaoka M.
        • et al.
        A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
        Immunology. 2009; 128: e170-e180
        • Naito S.
        • Koga H.
        • Yamaguchi A.
        • et al.
        Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.
        J Urol. 2008; 179: 485-490
        • Zlotta A.R.
        • Drowart A.
        • Van Vooren J.P.
        • et al.
        Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
        J Urol. 1997; 157: 492-498
        • Kato I.
        • Yokokura T.
        • Mutai M.
        Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
        Cancer Immunol Immunother. 1988; 26: 215-221
        • Chen F.
        • Zhang G.
        • Iwamoto Y.
        • et al.
        BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking.
        BMC Urol. 2005; 5
        • Nadler N.
        • Kvich L.
        • Bjarnsholt T.
        • et al.
        The discovery of bacterial biofilm in patients with muscle invasive bladder cancer.
        APMIS. 2021; 129: 265-270